Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | PTAFR | P25105 | 1/20 | 0.41 |
| ▸ | HTR1D | P28221 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.41 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.40 |
| ▸ | PGD | P52209 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
| ▸ | SELP | P16109 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23219279 | 0.91 | PGD (0.45) | FABP3LPAR3LPAR1MAPTENPP2 | |
| SCHEMBL5959944 | 0.90 | FABP3 (0.51) | FABP3LPAR3LPAR1MAPTENPP2 | |
| SCHEMBL5959467 | 0.87 | PLA2G2C (0.47) | FABP3LPAR3LPAR1MAPTENPP2 | |
| SCHEMBL4572659 | 0.87 | PLA2G2C (0.47) | FABP3LPAR3LPAR1MAPTENPP2 | |
| SCHEMBL12606860 | 0.84 | FABP3 (0.60) | FABP3MAPTSMN1; SMN2ADRA1DPTAFR | |
| SCHEMBL5959434 | 0.84 | FABP3 (0.60) | FABP3MAPTSMN1; SMN2ADRA1DPTAFR | |
| SCHEMBL13430956 | 0.84 | FABP3 (0.40) | FABP3LPAR3LPAR1MAPTENPP2 | |
| SCHEMBL13189423 | 0.84 | FABP3 (0.40) | FABP3LPAR3LPAR1MAPTENPP2 | |
| SCHEMBL15385430 | 0.84 | SELP (0.42) | FABP3LPAR3LPAR1MAPTENPP2 | |
| SCHEMBL26227625 | 0.83 | FABP3 (0.39) | FABP3LPAR3LPAR1MAPTENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226102-A1 | PHARMACEUTICAL COMPOSITIONS | Shenzhen Pharmacin Co., Ltd. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20230338371-A1 | PHARMACEUTICAL COMPOSITIONS OF PROTAC COMPOUNDS AND USES THEREOF | Shenzhen Pharmacin Co., Ltd. (CN) | 2023-10-26 | — | — | US | disclosed |
| US-20230128252-A1 | PHARMACEUTICAL COMPOSITIONS | Shenzhen Pharmacin Co., Ltd. (CN) | 2023-04-27 | — | — | US | disclosed |
| US-20150258221-A1 | Paramagnetic Solid Lipid Nanoparticles (pSLNs) Containing Metal Amphiphilic Complexes For MRI | BRACCO IMAGING S.P.A. (IT) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128252-A1 | PHARMACEUTICAL COMPOSITIONS | SLCO4C1, SLCO1B1, SLCO1A2 | FABP3 1797/4885LPAR3 3530/4885LPAR1 3810/4885 |
| US-20230338371-A1 | PHARMACEUTICAL COMPOSITIONS OF PROTAC COMPOUNDS AND USES THEREOF | ADRM1, PSMC1, UBE3C | FABP3 1601/4885LPAR3 2482/4885LPAR1 2923/4885 |
| US-20150258221-A1 | Paramagnetic Solid Lipid Nanoparticles (pSLNs) Containing Metal Amphiphilic Complexes For MRI | PLIN3, PEX3, SLC39A3 | FABP3 29/4885LPAR3 344/4885LPAR1 1657/4885 |
| US-20240226102-A1 | PHARMACEUTICAL COMPOSITIONS | ABL1, ABCG2, LIPA | FABP3 3142/4885LPAR3 1566/4885LPAR1 1858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.